ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
1.570
-0.020 (-1.26%)
Jun 11, 2026, 3:58 PM CET
ExpreS2ion Biotech Holding AB Employees
ExpreS2ion Biotech Holding AB had 19 employees as of March 31, 2026. The number of employees increased by 1 or 5.56% compared to the same quarter last year.
Employees
19
Change
1
Growth
5.56%
Revenue / Employee
848.32K SEK
Profits / Employee
-1.91M SEK
Market Cap
5.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 19 | 1 | 5.56% | 19 | 0 |
| Dec 31, 2025 | 20 | 2 | 11.11% | 20 | 0 |
| Sep 30, 2025 | 20 | 2 | 11.11% | 20 | 0 |
| Jun 30, 2025 | 20 | 2 | 11.11% | 20 | 0 |
| Mar 31, 2025 | 18 | 0 | - | 18 | 0 |
| Dec 31, 2024 | 18 | -3 | -14.29% | 18 | 0 |
| Sep 30, 2024 | 18 | -14 | -43.75% | 18 | 0 |
| Jun 30, 2024 | 18 | -14 | -43.75% | 18 | 0 |
| Mar 31, 2024 | 18 | -10 | -35.71% | 18 | 0 |
| Dec 31, 2023 | 21 | -8 | -27.59% | 21 | 0 |
| Jun 30, 2023 | 32 | 3 | 10.34% | 32 | 0 |
| Mar 31, 2023 | 28 | 2 | 7.69% | 28 | 0 |
| Dec 31, 2022 | 29 | 1 | 3.57% | 26 | 3 |
| Sep 30, 2022 | 26 | 3 | 13.04% | 26 | 0 |
| Jun 30, 2022 | 29 | 9 | 45.00% | 29 | 0 |
| Mar 31, 2022 | 26 | 9 | 52.94% | 26 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Magle Chemoswed Holding AB | 144 |
| 2cureX AB | 14 |
| Guard Therapeutics International AB | 12 |
| Fluicell AB | 11 |
| Alzinova AB | 7 |
| Spago Nanomedical AB | 7 |
| NanoEcho AB | 5 |
| Aptahem AB | 3 |
ExpreS2ion Biotech Holding AB News
- 14 days ago - ExpreS2ion Biotech Holding AB Earnings Call Transcript: Q1 2026 - Transcripts
- 14 days ago - ExpreS2ion Biotech Holding AB Quarterly report: Q1 2026 - Filings
- 14 days ago - ExpreS2ion Biotech Holding AB Slides: Q1 2026 - Filings
- 4 months ago - ExpreS2ion Biotech Holding AB Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - ExpreS2ion Biotech Holding AB Quarterly report: Q4 2025 - Filings
- 4 months ago - ExpreS2ion Biotech Holding AB Slides: Q4 2025 - Filings
- 7 months ago - ExpreS2ion Biotech Holding AB Transcript: Life Science Summit 2025 - Transcripts
- 7 months ago - ExpreS2ion Biotech Holding AB Earnings Call Transcript: Q3 2025 - Transcripts